{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T23:06:34Z","timestamp":1774566394351,"version":"3.50.1"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,14]]},"DOI":"10.7759\/cureus.101528","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T15:54:38Z","timestamp":1768406078000},"source":"Crossref","is-referenced-by-count":1,"title":["Second Primary Subglottic Laryngeal Carcinoma After Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone (CHOP) Chemotherapy for Non-Hodgkin Lymphoma"],"prefix":"10.7759","author":[{"given":"Cijo","family":"Sanal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isha","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pratikshya","family":"Biswal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lahunshisha","family":"Kharbuli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/87.7.524","article-title":"Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma","volume":"87","author":"Travis LB","year":"1995","unstructured":"Travis LB, Curtis RE, Glimelius B, et al.. Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma. J Natl Cancer Inst. 1995, 87:524-30. 10.1093\/jnci\/87.7.524","journal-title":"J Natl Cancer Inst"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.102248","article-title":"Treatment-specific risk of subsequent malignant neoplasms in five-year survivors of diffuse large B-cell lymphoma","volume":"9","author":"Geurts YM","year":"2024","unstructured":"Geurts YM, Neppelenbroek SI, Aleman BM, et al.. Treatment-specific risk of subsequent malignant neoplasms in five-year survivors of diffuse large B-cell lymphoma. ESMO Open. 2024, 9:102248. 10.1016\/j.esmoop.2024.102248","journal-title":"ESMO Open"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199304083281404","article-title":"Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma","volume":"328","author":"Fisher RI","year":"1993","unstructured":"Fisher RI, Gaynor ER, Dahlberg S, et al.. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma. N Engl J Med. 1993, 328:1002-6. 10.1056\/NEJM199304083281404","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier B","year":"2002","unstructured":"Coiffier B, Lepage E, Briere J, et al.. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002, 346:235-42. 10.1056\/NEJMoa011795","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijscr.2019.10.073","article-title":"Pancreatic neuroendocrine tumor, lymphoma, and squamous cell carcinoma of hypopharynx; a case report of three primary cancers in one patient","volume":"65","author":"Tangsirapat V","year":"2019","unstructured":"Tangsirapat V, Wongta K, Chakrapan Na Ayudhya K, Chakrapan Na Ayudhya V, Sookpotarom P. Pancreatic neuroendocrine tumor, lymphoma, and squamous cell carcinoma of hypopharynx; a case report of three primary cancers in one patient. Int J Surg Case Rep. 2019, 65:111-4. 10.1016\/j.ijscr.2019.10.073","journal-title":"Int J Surg Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1017\/S0022215120000729","article-title":"Head and neck squamous cell cancer associated with lymphoproliferative malignancies is aggressive","volume":"134","author":"Li L","year":"2020","unstructured":"Li L, Hamilton L, Montgomery J, Stewart M. Head and neck squamous cell cancer associated with lymphoproliferative malignancies is aggressive. J Laryngol Otol. 2020, 134:460-2. 10.1017\/S0022215120000729","journal-title":"J Laryngol Otol"},{"key":"ref7","article-title":"Secondary leiomyosarcoma after treatment of diffuse large B-cell lymphoma: a case report and literature review","volume":"12","author":"Wei S","year":"2019","unstructured":"Wei S, Wang J, Li Y, Chen L. Secondary leiomyosarcoma after treatment of diffuse large B-cell lymphoma: a case report and literature review. Int J Clin Exp Med. 2019, 12:1071-5.","journal-title":"Int J Clin Exp Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.5139","article-title":"Secondary malignancies in non-Hodgkin lymphoma survivors: 40\u2009years of follow-up assessed by treatment modality","volume":"12","author":"Parsons MW","year":"2023","unstructured":"Parsons MW, Rock C, Chipman JJ, et al.. Secondary malignancies in non-Hodgkin lymphoma survivors: 40\u2009years of follow-up assessed by treatment modality. Cancer Med. 2023, 12:2624-36. 10.1002\/cam4.5139","journal-title":"Cancer Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/417482-second-primary-subglottic-laryngeal-carcinoma-after-cyclophosphamide-doxorubicin-vincristine-and-prednisolone-chop-chemotherapy-for-non-hodgkin-lymphoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T15:54:38Z","timestamp":1768406078000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/417482-second-primary-subglottic-laryngeal-carcinoma-after-cyclophosphamide-doxorubicin-vincristine-and-prednisolone-chop-chemotherapy-for-non-hodgkin-lymphoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.101528","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,14]]}}}